ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

NRX Nurexone Biologic Inc

0,59
-0,01 (-1,67%)
03 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Nurexone Biologic Inc NRX TSX Venture Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,01 -1,67% 0,59 16:36:43
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
0,60 0,58 0,61 0,59 0,60
mais cotações »

Notícias Recentes

Data Hora Fonte Título
25/04/202412:30APSShares of Biopharma Up After News of Uplisting
25/04/202409:35GLOBENurExone Biologic Inc. Announces Strategic Expansion to US..
19/04/202417:04GLOBENurExone Presenting on Revolutionary Spinal Cord Injury..
02/04/202409:31GLOBENurExone Reports Fourth Quarter and Year Ended December 31,..
27/03/202418:05GLOBEGross Proceeds Close of $4M CAD Generated for NurExone From..
22/03/202418:04GLOBEIn Preparation for Expected Human Clinical Trials, NurExone..
15/03/202417:05GLOBENurExone's Strategic Update: Submission of OTCQB Listing..
08/03/202418:05GLOBENurExone establishing State-of-the-Art Research and..
01/03/202418:04GLOBENurExone Presenting Novel Regulatory Pathways for Exosomes..
20/02/202418:05GLOBENurExone’s Intellectual Property Portfolio Expands
14/02/202418:20GLOBENurExone Launches Licensing Efforts for ExoTherapy Platform
02/02/202418:05GLOBENurexone Biologic Initiates European Orphan Drug Designation..
17/01/202410:34GLOBENurExone and Inteligex Kick Off Chronic Spinal Cord Injury..
05/01/202410:30GLOBENurExone Announces Closing of a Private Placement for Gross..
29/11/202310:30GLOBENurExone Biologic Extends Spinal Cord Injury Therapy..
24/11/202310:30GLOBENurExone Reports Third Quarter 2023 Financial Results and..
16/11/202318:21APSTake Part in the Next Generation of Spinal Cord Injury..
07/11/202318:01APSOrphan Drugs Worth $64 Billion by 2028 and This Micro Cap..
31/10/202318:00APSWhen Technicals and Fundamentals Converge, A Nice Uptrend..
30/10/202314:00APSShares Up Following Orphan Drug Designation
30/10/202310:20GLOBENurExone Biologic Receives FDA Orphan-Drug Designation,..
25/10/202318:18APSMicrocap Offers Unique Opportunity for Investors In $10..
19/10/202309:30GLOBEAppointment of Professor Teo Forcht Dagi to Scientific..
18/10/202318:07APSNew Collaboration Could Revolutionize Treatment of Chronic..
11/10/202311:00APSSmall Company Working on Big Breakthrough in Treating Spinal..
11/10/202309:30GLOBENurExone Secures Eureka Grant for Collaborative..
05/10/202309:30GLOBENurExone Biologic to Present Exosome-Based Therapy for..
28/09/202309:30GLOBENurExone Appoints Dr. Reuter Investor Relations in Europe
13/09/202309:30GLOBENurExone Moves Forward Towards Human Clinical Trials,..
06/09/202309:30GLOBENurExone Announces Closing of Second Tranche of Private..
09/08/202309:00GLOBENurExone Announces Private Placement
20/07/202309:15GLOBENurExone Biologic Announces Advancements in Extracellular..
22/06/202309:00GLOBERegeneration and Reinnervation of Spinal Cord in Rats..
01/06/202309:00GLOBENurExone and Particle Metrix Announce Collaboration in..
16/05/202309:30GLOBENurExone Granted U.S. Patent for Technology and Drug..

Seu Histórico Recente

Delayed Upgrade Clock